Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year

被引：58
|
作者：
Winslow, Rebecca L. [1 ]
Milligan, Iain D. [1 ]
Voysey, Merryn [2 ]
Luhn, Kerstin [3 ]
Shukarev, Georgi [3 ]
Douoguih, Macaya [3 ]
Snape, Matthew D. [1 ]
机构：
[1] Univ Oxford, Dept Paediat, Oxford, England
[2] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[3] Janssen, Leiden, Netherlands
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 317卷 / 10期
关键词：
DISEASE;
D O I：
10.1001/jama.2016.20644
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1074 / 1077
页数：3
相关论文
共 50 条
  • [1] Safety and Immunogenicity of Novel Adenovirus Type 26-and Modified Vaccinia Ankara-Vectored Ebola Vaccines A Randomized Clinical Trial
    Milligan, Iain D.
    Gibani, Malick M.
    Sewell, Richard
    Clutterbuck, Elizabeth A.
    Campbell, Danielle
    Plested, Emma
    Nuthall, Elizabeth
    Voysey, Merryn
    Silva-Reyes, Laura
    McElrath, M. Juliana
    De Rosa, Stephen C.
    Frahm, Nicole
    Cohen, Kristen W.
    Shukarev, Georgi
    Orzabal, Nicola
    van Duijnhoven, Wilbert
    Truyers, Carla
    Bachmayer, Nora
    Splinter, Daniel
    Samy, Nathaly
    Pau, Maria Grazia
    Schuitemaker, Hanneke
    Luhn, Kerstin
    Callendret, Benoit
    Van Hoof, Johan
    Douoguih, Macaya
    Ewer, Katie
    Angus, Brian
    Pollard, Andrew J.
    Snape, Matthew D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15): : 1610 - 1623
  • [2] Safety and Immunogenicity of Heterologous and Homologous 2-Dose Regimens of Adenovirus Serotype 26-and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized, Controlled Phase 1 Study
    Goldstein, Neil
    Bockstal, Viki
    Bart, Stephan
    Luhn, Kerstin
    Robinson, Cynthia
    Gaddah, Auguste
    Callendret, Benoit
    Douoguih, Macaya
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (04): : 595 - 607
  • [3] Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model
    Julander, Justin G.
    Testori, Marco
    Cheminay, Cedric
    Volkmann, Ariane
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] Safety and immunogenicity of novel modified vaccinia Ankara-vectored RSV vaccine: A randomized phase I clinical trial
    Samy, Nathaly
    Reichhardt, Daniela
    Schmidt, Darja
    Chen, Liddy M.
    Silbernagl, Guenter
    Vidojkovic, Sanja
    Meyer, Thomas P. H.
    Jordan, Elke
    Adams, Tatiana
    Weidenthaler, Heinz
    Stroukova, Dania
    De Carli, Sonja
    Chaplin, Paul
    VACCINE, 2020, 38 (11) : 2608 - 2619
  • [5] Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction
    Hanke, Tomas
    McMichael, Andrew J.
    Dorrell, Lucy
    JOURNAL OF GENERAL VIROLOGY, 2007, 88 : 1 - 12
  • [6] Specific Immune Responses and Oncolytic Effects Induced by EBV LMP2A-Armed Modified Ankara-Vaccinia Virus Vectored Vaccines in Nasopharyngeal Cancer
    Sun, Liying
    Liu, Chao
    Peng, Junping
    PHARMACEUTICS, 2025, 17 (01)
  • [7] Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines
    Chapman, Rosamund
    van Diepen, Michiel
    Douglass, Nicola
    Hermanus, Tandile
    Moore, Penny L. L.
    Williamson, Anna-Lise
    VACCINES, 2023, 11 (02)
  • [8] Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines
    Mullin, Jennifer
    Ahmed, Muhammed S.
    Sharma, Ravi
    Upile, Navdeep
    Beer, Helen
    Achar, Priya
    Puksuriwong, Suttida
    Ferrara, Francesca
    Temperton, Nigel
    McNamara, Paul
    Lambe, Teresa
    Gilbert, Sarah C.
    Zhang, Qibo
    VACCINE, 2016, 34 (14) : 1688 - 1695
  • [9] Genetically modified rabies virus-vectored Ebola virus disease vaccines are safe and induce efficacious immune responses in mice and dogs
    Shuai, Lei
    Wang, Xijun
    Wen, Zhiyuan
    Ge, Jinying
    Wang, Jinliang
    Zhao, Dandan
    Bu, Zhigao
    ANTIVIRAL RESEARCH, 2017, 146 : 36 - 44
  • [10] Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction (vol 88, pg 1, 2007)
    Hanke, Tomas
    Goonetilleke, Nilu
    McMichael, Andrew J.
    Dorrell, Lucy
    JOURNAL OF GENERAL VIROLOGY, 2008, 89 : 609 - 609
12345